active: true
address:
    address1: 110 EAST 59TH STREET
    city: NEW YORK
    postal_code: '10022'
    state: NY
branding:
    logo_url: https://api.polygon.io/v1/reference/company-branding/cm95YWx0eXBoYXJtYS5jb20/images/2025-04-04_logo.svg
cik: 0001802768
currency_name: usd
description: Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties.
    The firm has a portfolio of royalties that entitles it to payments based on the
    sales of biopharma products. Royalty Pharma receives royalties on more than 35
    commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic
    lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing
    forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage
    product candidates.
homepage_url: https://www.royaltypharma.com
list_date: '2020-06-16'
locale: us
market: stocks
market_cap: 15761404603.0
name: Royalty Pharma plc Class A Ordinary Shares
phone_number: (212) 883-0200
primary_exchange: XNAS
round_lot: 100
share_class_shares_outstanding: 432293050
sic_code: '2834'
sic_description: PHARMACEUTICAL PREPARATIONS
ticker: RPRX
ticker_root: RPRX
total_employees: 99
type: CS
weighted_shares_outstanding: 432293050
